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Ten-year Experience in Autogenous Reconstruction with the Femoral
Vein in the Treatment of Aortofemoral Prosthetic Infection
K. Daenens, I. Fourneau and A. Nevelsteen
Center for Vascular Diseases, University Hospital Gasthuisberg, Leuven, Belgium
Objective: to study the short and long term effectiveness of in situ replacement of infected aortic grafts with the lower
extremity deep veins.
Methods: forty-nine patients operated on for infrarenal aortic graft infection since 1990 were studied. Diagnosis of
infection was based on clinical signs, bacteriological tests and typical findings on CT scan and leukocyte scan. The surgical
treatment consisted in harvesting the femoral vein, total graft excision, thorough debridement and in situ reconstruction
with the femoral veins. After discharge, the patients were followed at 6 monthly intervals with clinical examination, duplex
and/or CT scan.
Results: there were four in-hospital deaths (8%). One patient required above-knee amputation (2%) and there were two
graft limb occlusions (4%). With a mean follow-up 41 months, another 13 patients died, unrelated to the operation (29%).
There were no late amputations and only two late graft limb stenoses (4%). We have a 5 year survival rate of 60%, a 5 year
limb salvage rate of 98%, and a 5 year primary patency rate of 91%. There were no cases of aneurysmal dilatation of vein
grafts and no incidence of reinfection.
Conclusion: in situ reconstruction with the lower extremity deep veins is in the long term a safe and attractive alternative
in the treatment of infrarenal aortic graft infection.
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Introduction
Deep infection remains the most feared complication
after prosthetic infrarenal aortic surgery. It is an infre-
quent complication, affecting only 2% of the patients
but if untreated it is invariably fatal. Local therapy
with antibiotics is rarely sufficient and only indicated
in high-risk patients with localised infection.1±4 Extra
anatomic bypass with total graft excision is consi-
dered to be the gold standard. However, there is a
substantial problem with recurrent infection and com-
plications related to the extra-anatomic technique.1,5
In order to avoid these complications, we started in situ
reconstruction with the lower extremity deep veins.
Following our previous preliminary publication,6 the
present report describes our further experience with
extended follow-up.
Patients and Methods
Patients
Since 1990, 70 patients with infrarenal aortic graft
infection were treated by an autogenous in situ recon-
struction, using the lower extremity deep veins.
Twenty-one patients presented with graft-enteric com-
plications. These will be the subject of a subsequent
report. In this study, we focus on 49 patients who
presented with a primary graft infection in the
absence of aorto-enteric complications. Data concern-
ing demographics, preoperative presentation, opera-
tive details and postoperative period were retrieved
from the prospective records, kept in the database of
all operated patients in the Department of Vascular
Surgery since 1990.
Operative procedure
The operation technique has already been described
in previous reports.6±8 With a ten-year experience we
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now emphasise certain details. Preoperative duplex
ultrasound examination is essential to assess the
patency and size of the femoral vein (FV). The oper-
ation starts with harvesting the FV from both legs. We
take care to preserve the greater saphenous vein (GSV)
since there are indications that this might lower the
postoperative venous morbidity. However, in our ser-
ies there were several patients where the GSV had
already been removed in previous vascular interven-
tions. There must be no FV-stump left at the junction
of the common femoral vein to maintain a correct flow
from the profunda femoris into the common femoral
vein. To prevent contamination, the wounds are
closed before laparotomy. The infected prosthesis is
completely excised and most important of all, a thor-
ough retroperitoneal debridement is performed. Sam-
ples of the infected tissues and graft are taken for
bacteriology. Initially, we created an end-to-end anas-
tomosis with the reversed veins sewn together in a
pantaloon configuration (high bifurcation, Fig. 1A).
Since 1995 we changed our technique and we actually
prefer to downsize the infrarenal aortic cuff and to
create an end-to-end anastomosis with only one vein
while the second vein is connected more distally on
the first one (low bifurcation, Fig. 1B). The vein
grafts are covered with viable tissues without
leaving residual cavities. Omentoplasty is generally
used at the proximal anastomosis and a rectus
femoris muscle flap in the groin is provided if neces-
sary (extensive groin infection). Wounds are closed
on suction drains in the femoral region and in the
retroperitoneum.
Postoperative management
Intermittent pneumatic compression for 5 days, low
molecular weight heparin during the hospital stay
and elastic stockings for 3 months were used to pre-
vent venous thrombosis and hypertension. Intraven-
ous antibiotic therapy was based on preoperative
cultures and antibiotic sensitivity. In the absence of
positive preoperative cultures, Vancomycin was
started peroperatively after taking bacteriological
samples. Antibiotic therapy was directed postopera-
tively if necessary and continued for 6 weeks. After
discharge, all patients have been seen at 6-months
intervals with clinical vascular examination and
duplex ultrasound to evaluate the reconstruction. CT
scan, leukocyte scan or angiography was only per-
formed in selected cases.
Results
Patients
The mean age of the 49 patients was 65 years (47±78
years). There were 45 men and four women. Their
primary operation was performed for occlusive dis-
ease in 34 cases and for aneurysms in 15 cases. Eleven
of these primary operations were performed in our
Department. All procedures were done with Dacron
grafts and included aorto-bi-femoral reconstructions
(n 43), aorto-bi-iliac grafts (n 3) and aorto-aortic
tube grafts (n 3). The mean interval between the
initial operation and the diagnosis of prosthetic infec-
tion was 59 months (1±307 months). Twenty-three
patients received already some treatment in an
attempt to control the infection: abscess drainage
(n 13), correction of false aneurysm (n 3), other
vascular procedures (n 3) or antibiotics (n 4).
Suspicion of infection was based on clinical signs
(Table 1). Out of the four patients suffering severe
ischemic complications, two presented with rest pain
Fig. 1. Schematic drawing of in situ aortofemoral reconstruction
with the femoral veins: the high bifurcation technique (A) and the
low bifurcation technique (B).
Table 1. Clinical presentation in 49 patients.
n
Sepsis 21
Abscess (groin n 10) 12
Cutaneous fistula (groin n 13) 15
Femoral false aneurysm 11
Anastomotic aorta rupture 1
Septic emboli 1
Graft thrombosis 6
Claudication 2
Restpain 2
Acute ischemia 2
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and another two with acute ischemia. Evidence of
infection was achieved by CT scan, by leukocyte scan
and by bacteriological tests. CT scan showed perigraft
masses, fluid or abscesses, located in the retroperito-
neum in 23 cases and in the groin in 34 cases. Indirect
signs as vertebral column invasion (n 2) or hydrone-
phrosis (n 2) helped with the diagnosis. Leukocyte
scan was performed in 22 patients and 18 were posi-
tive. The infections were due to a variety of organisms
with staphylococci being the most frequent one
(Table 2). Other organisms included Escherichia coli,
Pseudomonas aeruginosa and MRSA. Polymicrobial
infections were seen in 10 patients while no organisms
were cultured in four patients.
Operation
All but two reconstructions were done on an elective
base. The femoral veins were always harvested from
both limbs. The infected prosthesis was completely
excised in all patients. The following reconstructions
were performed: 44 aorto-bi-femoral bypasses, three
aorto-bi-iliac and two aorto-iliac/femoral bypasses.
For technical reasons, the three aortic tube grafts
were replaced by an venous aorto-bi-iliac graft. The
high bifurcation technique was used in 20 patients
and the low bifurcation technique in 29 patients. One
patient required splenectomy for a per-operative
trauma. Reimplantation of a renal artery was neces-
sary in one case and reimplantation of an internal iliac
artery in two cases. Hydro-ureteronephrosis was trea-
ted by a double-J stent in two patients. Omentoplasty
was performed in 25 patients. Concomitant vascular
procedures were one femorofibular venous homograft
and one saphenous vein femoropopliteal bypass
below the knee. A muscle flap in the groin was used
in 6 cases. A fasciotomy was never done and one
surgical team performed all procedures.
Early results
There were 4 in-hospital deaths (8%) (Table 3). Two
patients died due to abdominal complications and
multiple organ system failure: one sigmoid necrosis
and one intra-abdominal bleeding. The third patient
developed a fatal myocardial infarction and the fourth
died after a cerebrovascular accident. Postoperative
morbidity included revision for major bleeding in
four cases. Respiratory complications were encoun-
tered in 10 patients: one with Adult Respiratory Dis-
tress Syndrome, eight with pneumonia and one lung
embolism. Above-knee amputation was necessary in
only one patient (2%) after occlusion of the femorofib-
ular venous homograft, performed concomitantly to
the venous reconstruction. There were two graft limb
occlusions (4%). One was treated by thrombectomy
and subsequent stenting while the second graft
thrombosis was left alone (asymptomatic occlusion).
Late results
The mean follow-up time was 41 months (range 1±101
months). There were 13 late deaths (29%), unrelated to
the operative reconstruction (six myocardial infarc-
tions, three lung cancers, and four other cancers).
The 5 year survival rate was 60% (Fig. 2A). There
were no late amputations (5 years limb salvage rate
of 98%, Fig. 2B) but two late graft limb stenoses (4%),
both treated by balloon dilation and stenting (5 year
primary patency rate of 91%, Fig. 2C). Venous mor-
bidity was low and only three patients (6%) required
elastic stockings longer than 6 months. Careful
follow-up with duplex ultrasound and/or CT scan
showed continuous function of the venous graftTable 2. Organisms grown in 49 patients.
n
Coagulase Negative Staphylococcus 23
Staphylococcus aureus 15
Escherichia coli 4
Pseudomonas aeruginosa 2
MRSA 2
Corynebacterium 2
Acinetobacter baumannii 1
Aspergillus funginatum 1
Bacteroides fragilis 1
Enterobacter 1
Enterococcus faecalis 1
Klebsiella oxytoca 1
Morganella morgani 1
Rosemonas 1
No growth 4
Table 3. Operative mortality and morbidity.
n
In-hospital deaths (8%) 4
MOSF 2
AMI 1
CVA 1
Major post-operative bleeding 4
ARDS 1
Pneumonia 8
Lung embolism 1
Above-knee amputation 1
Graft limb occlusion 2
DVT 1
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without any aneurysmal degeneration (Fig. 3). Finally
and most importantly, infection remained cured in all
patients.
Discussion
Graft excision and extra-anatomic bypass is the trad-
itional treatment of infrarenal aortofemoral prosthetic
infection.1,2 Results may have been improved over the
years but mortality and morbidity remains high.1,5
Dissatisfaction with this technique led to a revival of
in situ reconstruction over the last decade. In situ
reconstruction was introduced mainly to avoid aortic
stump blow-out, extra-anatomic graft failure, rein-
fection and the physiologic stress associated with
multiple or staged procedures.9 Nevertheless, our
results show that the mortality rates also compete
favourably with those of recent reports on graft exci-
sion and extra-anatomic bypass. Seeger et al. reported
in 2000 on 36 patients treated with the traditional
technique.5 Operative mortality was 19%, 11% needed
amputation and 35% had graft failure. There was one
reinfection and one aortic stump disruption.
Apart from the femoral vein, several authors have
described different methods of in situ reconstruction.
The use of the greater saphenous vein has been
abandoned due to poor patency in the long term.
Some studies report failure rates of 60%. Intimal
hyperplasia also seems to be important in these
small veingrafts.10,11
In our department, arterial homografts are some-
times used for lack of deep veins.12 With the new
techniques of cryopreservation, they have certainly
the advantage of availability and versatility.13,14
Nevertheless, they are less resistant to infection than
autogenous tissues and late degeneration remains a
possible risk. Kieffer et al. reported in 1997 his experi-
ence in 100 patients with aortofemoral prosthetic
infection treated by arterial homografts.13 The opera-
tive mortality rate was 19% for the patients with only
isolated prosthetic infection. There were two reinfec-
tions, two late aortic ruptures and five patients
showed aneurysmal dilatation of the homograft. Dur-
ing follow-up, 20 occlusive lesions were observed
(25%). His conclusion was that this technique seemed
to be a good alternative but that complete protection
against persistent or recurrent infection cannot be
guaranteed and that late deterioration is a possible
risk. This was also our experience when we reported
a 6.6% reinfection rate and a 23% incidence of
occlusive complications in a series of 30 patients.12
In addition, Verhelst et al. documented in a multi-
centric study a high failure rate in case of virulent
infections.15
The experience of in situ reconstruction with
impregnated Dacron grafts is still limited. Hayes
Fig. 3. 3D CT reconstruction of venous aortofemoral graft (high
bifurcation technique) after 6 years.
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Fig. 2. Cumulative 5 years survival rate (A), limb salvage rate (B) and primary patency rate (C).
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et al. reported in 1999 on 11 patients over a period of
7 years, treated by in situ replacement with a
rifampicin-bonded prosthesis.16 The operative morta-
lity rate was 18.2% and seven patients remained alive
and free of infection. The conclusion was that the
results appeared to be favourable but the MRSA infec-
tion was associated with a poor prognosis. In a recent
review on the role of rifampicin-impregnated grafts,
Earnshaw concluded that this technique is probably
best avoided in patients with extensive perigraft infec-
tion.17 Young et al. reported also in 1999 on 25 patients
treated with a Dacrongraft and nine of them where
rifampicin-soaked.18 They present an 8% operative
mortality, a 100% limb salvage rate and an 86% 5 year
graft patency rate. On the other hand, they have a
22% reinfection rate, despite lifelong antibiotics. Never-
theless, there was a trend of lower reinfection rates
with rifampicin-impregnated grafts. More recently,
Zegelman and GuÈ nther reported their experience
with silver coated grafts on a series of 62 patients.19
The operative mortality rate of 6.5% is very acceptable
but there is still a reinfection rate of 6.5%.
The major advantage of the femoral vein is its high
resistance to infection. With this autologous graft, we
had indeed no reinfections in our series. This confirms
the reports of Clagett et al. who also stressed the
durability and resistance of the femoral vein in high
virulent infections.7 However, reinfection has been
reported with P. aeruginosa20 and MRSA.21 It has also
been reported that P. aeruginosa or an aggressive mix
of bacteria could cause an acute disruption or dehis-
cence of the suture line, even in grafts constructed
from autologous material.22 In our series there were
two patients with P. aeruginosa and two with MRSA
infection. All four patients recovered without pro-
blems. Although caution might be advised in these
cases, we feel that our results might be at least partial-
ly explained by our operative technique with exten-
sive debridement of all infected tissues and the
prolonged antibiotic regimen we use postoperatively.
Furthermore, there is only minimal venous morbidity
after harvesting the femoral vein23±25 and until now,
the reports about this type of in situ reconstruction
never showed aneurysmal dilatation of the vein
graft.7,20,26±28 On the other hand, it is agreed that
in situ reconstruction with the femoral vein is a tech-
nically more demanding and time-consuming proced-
ure, lasting around 6 h. Harvesting is also more
difficult after previous femoropopliteal bypass. In
addition, there might be a problem with the availabil-
ity and the amount of venous material. Both femoral
veins are certainly sufficient for the aorto-bi-femoral
reconstruction but concomitant vascular procedures
may create a problem. The only contra-indication for
harvesting the femoral vein is previous deep venous
thrombosis. Despite these limitations, we were able to
use the femoral vein in more than 80% of the
patients presenting with an infrarenal aortic graft
infection.
Treatment of aortic graft infection has to focus on
patient's survival, eradication of infection and revas-
cularisation of the lower extremities by a method,
which is safe, durable and does not become infected
itself. Based on this assumption, our results are cer-
tainly gratifying. We have an operative survival of 92%
with only one major amputation. The 5 year survival
rate is 60% but none of the late deaths were related to
the reconstructive procedure. In addition there were
no reinfections and the venous reconstruction proved
to be functional and durable on the long term.
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